This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Baere, T.
Right arrow Articles by Vaneechoutte, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Baere, T.
Right arrow Articles by Vaneechoutte, M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, September 2004, p. 4393-4395, Vol. 42, No. 9
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.9.4393-4395.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

CASE REPORT

Bacteremic Infection with Pantoea ananatis

Thierry De Baere,1 Rita Verhelst,1 Caroline Labit,2 Gerda Verschraegen,1 Georges Wauters,3 Geert Claeys,1 and Mario Vaneechoutte1*

Department of Clinical Chemistry, Microbiology & Immunology, University Hospital, Ghent,1 Department of Clinical Chemistry, St. Vincentius Hospital, Deinze,2 Medical Microbiology Unit, Université Catholique Louvain, Brussels, Belgium3

Received 17 March 2004/ Returned for modification 4 May 2004/ Accepted 16 May 2004

A 73-year-old man was hospitalized for dyspnea and bilateral ankle edema. During his hospital stay he presented anal hemorrhage and developed a high fever after colonoscopy. A set of aerobic and anaerobic blood culture bottles yielded a pure culture of gram-negative rods, susceptible to all antibiotics tested. The API20E code was 1005133, resulting in a very good identification as Pantoea sp. Subsequent sequencing of the 16S rRNA gene revealed a final identification as Pantoea ananatis. The patient was given intravenous and oral therapy with piperacillin-tazobactam and ofloxacin and recovered completely from his infection.

* Corresponding author. Mailing address: Department of Clinical Chemistry, Microbiology & Immunology, Blok A, University Hospital, Ghent, Belgium. Phone: 32 9 240 36 43. Fax: 32 9 240 36 59. E-mail: thierry.debaire{at}ugent.be.

Journal of Clinical Microbiology, September 2004, p. 4393-4395, Vol. 42, No. 9
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.9.4393-4395.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»